|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jin X, Chen Y, Chen H, Fei S, Chen D, Cai
X, Liu L, Lin B, Su H, Zhao L, et al: Evaluation of tumor-derived
exosomal miRNA as potential diagnostic biomarkers for Early-stage
non-small cell lung cancer using next-generation sequencing. Clin
Cancer Res. 23:5311–5319. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schrodl K, Oelmez H, Edelmann M, Huber RM
and Bergner A: Altered Ca2+-homeostasis of cisplatin-treated and
low level resistant non-small-cell and small-cell lung cancer
cells. Cell Oncol. 31:301–315. 2009.PubMed/NCBI
|
|
4
|
Koh ES, Sun A, Tran TH, Tsang R, Pintilie
M, Hodgson DC, Wells W, Heaton R and Gospodarowicz MK: Clinical
dose-volume histogram analysis in predicting radiation pneumonitis
in Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 66:223–228.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xing J, Stewart DJ, Gu J, Lu C, Spitz MR
and Wu X: Expression of methylation-related genes is associated
with overall survival in patients with non-small cell lung cancer.
Br J Cancer. 98:1716–1722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wakelee H, Kelly K and Edelman MJ: 50
Years of progress in the systemic therapy of non-small cell lung
cancer. Am Soc Clin Oncol Educ Book. 177–189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vitiello M, Tuccoli A and Poliseno L: Long
non-coding RNAs in cancer: Implications for personalized therapy.
Cell Oncol (Dordr). 38:17–28. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harries LW: Long non-coding RNAs and human
disease. Biochem Soc Trans. 40:902–906. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li DY, Chen WJ, Luo L, Wang YK, Shang J,
Zhang Y, Chen G and Li SK: Prospective lncRNA-miRNA-mRNA regulatory
network of long non-coding RNA LINC00968 in non-small cell lung
cancer A549 cells: A miRNA microarray and bioinformatics
investigation. Int J Mol Med. 40:1895–1906. 2017.PubMed/NCBI
|
|
11
|
Yang X, Gao L, Guo X, Shi X, Wu H, Song F
and Wang B: A network based method for analysis of lncRNA-disease
associations and prediction of lncRNAs implicated in diseases. PLoS
One. 9:e877972014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhong G, Lou W, Yao M, Du C, Wei H and Fu
P: Identification of novel mRNA-miRNA-lncRNA competing endogenous
RNA network associated with prognosis of breast cancer.
Epigenomics. 11:1501–1518. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu J, Fu H, Wu Y and Zheng X: Function of
lncRNAs and approaches to lncRNA-protein interactions. Sci China
Life Sci. 56:876–885. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meng Q, Ren M, Li Y and Song X:
LncRNA-RMRP acts as an oncogene in lung cancer. PLoS One.
11:e01648452016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang H, Yan L, Sun K, Sun X, Zhang X, Cai
K and Song T: lncRNA BCAR4 increases viability, invasion, and
migration of non-small cell lung cancer cells by targeting
glioma-associated oncogene 2 (GLI2). Oncol Res. 27:359–369. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng ZH, Wu DM, Fan SH, Zhang ZF, Chen GQ
and Lu J: Upregulation of miR-675-5p induced by lncRNA H19 was
associated with tumor progression and development by targeting
tumor suppressor p53 in non-small cell lung cancer. J Cell Biochem.
120:18724–18735. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang B, Zhang L, Cao Y, Chen S, Cao J, Wu
D, Chen J, Xiong H, Pan Z, Qiu F, et al: Overexpression of lncRNA
IGFBP4-1 reprograms energy metabolism to promote lung cancer
progression. Mol Cancer. 16:1542017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu L, Fang F, Lu S, Li X, Yang Y and Wang
Z: lncRNA-HIT promotes cell proliferation of non-small cell lung
cancer by association with E2F1. Cancer Gene Ther. 24:221–226.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sui J, Li YH, Zhang YQ, Li CY, Shen X, Yao
WZ, Peng H, Hong WW, Yin LH, Pu YP and Liang GY: Integrated
analysis of long non-coding RNA-associated ceRNA network reveals
potential lncRNA biomarkers in human lung adenocarcinoma. Int J
Oncol. 49:2023–2036. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Di Stefano P, Damiano L, Cabodi S, Aramu
S, Tordella L, Praduroux A, Piva R, Cavallo F, Forni G, Silengo L,
et al: p140Cap protein suppresses tumour cell properties,
regulating Csk and Src kinase activity. EMBO J. 26:2843–2855. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Summy JM and Gallick GE: Src family
kinases in tumor progression and metastasis. Cancer Metastasis Rev.
22:337–358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park SI, Shah AN, Zhang J and Gallick GE:
Regulation of angiogenesis and vascular permeability by Src family
kinases: Opportunities for therapeutic treatment of solid tumors.
Expert Opin Ther Targets. 11:1207–1217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu Y, Wang H and Mills GB: Targeting
PI3K-AKT pathway for cancer therapy. Rev Clin Exp Hematol.
7:205–228. 2003.PubMed/NCBI
|
|
25
|
Thakur R, Trivedi R, Rastogi N, Singh M
and Mishra DP: Inhibition of STAT3, FAK and Src mediated signaling
reduces cancer stem cell load, tumorigenic potential and metastasis
in breast cancer. Sci Rep. 5:101942015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kennedy S, Clynes M, Doolan P, Mehta JP,
Rani S, Crown J and O'Driscoll L: SNIP/p140Cap mRNA expression is
an unfavourable prognostic factor in breast cancer and is not
expressed in normal breast tissue. Br J Cancer. 98:1641–1645. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang P, Wang H, Li X, Liu Y, Zhao C and
Zhu D: SRCIN1 suppressed osteosarcoma cell proliferation and
invasion. PLoS One. 11:e01555182016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rousseaux S, Debernardi A, Jacquiau B,
Vitte AL, Vesin A, Nagy-Mignotte H, Moro-Sibilot D, Brichon PY,
Lantuejoul S, Hainaut P, et al: Ectopic activation of germline and
placental genes identifies aggressive metastasis-prone lung
cancers. Sci Transl Med. 5:186ra1662013. View Article : Google Scholar
|
|
31
|
Castro-Oropeza R, Melendez-Zajgla J,
Maldonado V and Vazquez-Santillan K: The emerging role of lncRNAs
in the regulation of cancer stem cells. Cell Oncol (Dordr).
41:585–603. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ulivi P, Foschi G, Mengozzi M, Scarpi E,
Silvestrini R, Amadori D and Zoli W: Peripheral blood miR-328
expression as a potential biomarker for the early diagnosis of
NSCLC. Int J Mol Sci. 14:10332–10342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gao Y, Xue Q, Wang D, Du M, Zhang Y and
Gao S: miR-873 induces lung adenocarcinoma cell proliferation and
migration by targeting SRCIN1. Am J Transl Res. 7:2519–2526.
2015.PubMed/NCBI
|
|
34
|
Portillo JC, Muniz-Feliciano L, Lopez
Corcino Y, Lee SJ, Van Grol J, Parsons SJ, Schiemman WP and
Subauste CS: Toxoplasma gondii induces FAK-Src-STAT3 signaling
during infection of host cells that prevents parasite targeting by
autophagy. PLoS Pathog. 13:e10066712017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao M, Hou D, Liang H, Gong F, Wang Y, Yan
X, Jiang X, Wang C, Zhang J, Zen K, et al: miR-150 promotes the
proliferation and migration of lung cancer cells by targeting SRC
kinase signalling inhibitor 1. Eur J Cancer. 50:1013–1024. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang N, Liang H, Zhou Y, Wang C, Zhang S,
Pan Y, Wang Y, Yan X, Zhang J, Zhang CY, et al: miR-203 suppresses
the proliferation and migration and promotes the apoptosis of lung
cancer cells by targeting SRC. PLoS One. 9:e1055702014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang M, Meng B and Liu Y, Yu J, Chen Q and
Liu Y: MiR-124 Inhibits Growth and enhances radiation-induced
apoptosis in non-small cell lung cancer by inhibiting STAT3. Cell
Physiol Biochem. 44:2017–2028. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang J, Lin J, Liu T, Chen T, Pan S, Huang
W and Li S: Analysis of lncRNA expression profiles in non-small
cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer.
85:110–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang T, Li H, Chen T, Ren H, Shi P and
Chen M: LncRNA MALAT1 depressed Chemo-sensitivity of NSCLC cells
through directly functioning on miR-197-3p/p120 Catenin Axis. Mol
Cells. 42:270–283. 2019.PubMed/NCBI
|
|
40
|
Zhang B, Wang H, Wang Q, Xu J, Jiang P and
Li W: Knockout of lncRNA UCA1 inhibits drug resistance to gefitinib
via targeting STAT3 signaling in NSCLC. Minerva Med. 110:273–275.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen EG, Zhang JS, Xu S, Zhu XJ and Hu HH:
Long non-coding RNA DGCR5 is involved in the regulation of
proliferation, migration and invasion of lung cancer by targeting
miR-1180. Am J Cancer Res. 7:1463–1475. 2017.PubMed/NCBI
|
|
42
|
Luo J, Zhu H, Jiang H, Cui Y, Wang M, Ni X
and Ma C: The effects of aberrant expression of LncRNA
DGCR5/miR-873-5p/TUSC3 in lung cancer cell progression. Cancer Med.
May 23–2018.(Epub ahead of print). View Article : Google Scholar
|
|
43
|
Liang Q, Ding J, Xu R, Xu Z and Zheng S:
The novel human endogenous retrovirus-related gene, psiTPTE22-HERV,
is silenced by DNA methylation in cancers. Int J Cancer.
127:1833–1843. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xie JJ, Guo QY, Jin JY and Jin D:
SP1-mediated overexpression of lncRNA LINC01234 as a ceRNA
facilitates non-small-cell lung cancer progression via regulating
OTUB1. J Cell Physiol. 234:22845–22856. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yan R, Jiang Y, Lai B, Lin Y and Wen J:
The positive feedback loop FOXO3/CASC11/miR-498 promotes the
tumorigenesis of non-small cell lung cancer. Biochem Biophys Res
Commun. 519:518–524. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ding H, Liu J, Zou R, Cheng P and Su Y:
Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma
progression by suppressing STAT3 phosphorylation. J Exp Clin Cancer
Res. 38:1892019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Luo T, Yan Y, He Q, Ma X and Wang W:
miR-328-5p inhibits MDA-MB-231 breast cancer cell proliferation by
targeting RAGE. Oncol Rep. 39:2906–2914. 2018.PubMed/NCBI
|
|
48
|
Wang C, Wang S, Ma F and Zhang W:
miRNA-328 overexpression confers cisplatin resistance in nonsmall
cell lung cancer via targeting of PTEN. Mol Med Rep. 18:4563–4570.
2018.PubMed/NCBI
|
|
49
|
Liu Z, Yu Y, Huang Z, Kong Y, Hu X, Xiao
W, Quan J and Fan X: CircRNA-5692 inhibits the progression of
hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP
expression. Cell Death Dis. 10:9002019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang S, Li P, Zhao L and Xu L: LINC00210
as a miR-328-5p sponge promotes nasopharyngeal carcinoma
tumorigenesis by activating NOTCH3 pathway. Biosci Rep. 38(pii):
BSR201811682018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Johnson FM and Gallick GE: SRC family
nonreceptor tyrosine kinases as molecular targets for cancer
therapy. Anticancer Agents Med Chem. 7:651–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Byers LA, Sen B, Saigal B, Diao L, Wang J,
Nanjundan M, Cascone T, Mills GB, Heymach JV and Johnson FM:
Reciprocal regulation of c-Src and STAT3 in non-small cell lung
cancer. Clin Cancer Res. 15:6852–6861. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen R, Liao JY, Huang J, Chen WL, Ma XJ
and Luo XD: Downregulation of SRC Kinase signaling inhibitor 1
(SRCIN1) expression by MicroRNA-32 promotes proliferation and
Epithelial-mesenchymal transition in human liver cancer cells.
Oncol Res. 26:573–579. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yang F, Luo LJ, Zhang L, Wang DD, Yang SJ,
Ding L, Li J, Chen D, Ma R, Wu JZ and Tang JH: MiR-346 promotes the
biological function of breast cancer cells by targeting SRCIN1 and
reduces chemosensitivity to docetaxel. Gene. 600:21–28. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Han N, Zhao W, Zhang Z and Zheng P:
MiR-328 suppresses the survival of esophageal cancer cells by
targeting PLCE1. Biochem Biophys Res Commun. 470:175–180. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liang F, Cui ZJ, Liu JD, Liu KP, Li L and
Chen YL: Downregulated miR-328 suppressed cell invasion and growth
in hepatocellular carcinoma via targeting PTEN. Eur Rev Med
Pharmacol Sci. 22:6324–6332. 2018.PubMed/NCBI
|
